An article entitled “The silent treatment: How Canada has failed MS sufferers” has been published by Macleans.ca and it exposes government emails that clearly demonstrate how political concerns were put ahead of scientific evidence and opinions on the progress of clinical CCSVI trials in Canada.
On June 3rd 2010 Peter Liu, a scientific director of the Canadian Institutes of Health Research (CIHR) in Ottawa, sent an internal email to CIHR executives who had asked him his opinion on CCSVI and its links with MS. In his response he said: “My own interpretation of the data is that CCSVI is likely a contributing factor in a restricted subset of MS patients.”
“We need a much larger multi-centre trial, including merging some of the ongoing trials, or developing patient selective criteria to narrow down to [a] group that will respond.”
But the Canadian government ignored this advice and continued to delay initiating any kind of research on CCSVI. Canadians travelled abroad for CCSVI treatment as they grew fed up with waiting for the treatment to become available to them in their home country.
Then in the summer of 2011 Liberal MP Kirsty Duncan announced plans to table a bill calling for a “national CCSVI strategy”. Her action threatened to turn the issue into a political debate, and a week later the CIHR found evidence to justify trials. Five months later, it invited proposals. On April 18, 2012, Health Minister Leona Aglukkaq announced a proposal had been selected. But a CIHR press release said that he researcher’s identity will only be revealed “if and when ethics approval is granted,” making for a confusing statement and enduring lack of information and progress on this issue.
To read the full article on why Canada has not kept its promise to speed up clinical trials for CCSVI and MS, please see the Macleans.ca website.
Here at Angeles Health we offer CCSVI treatment that is safe and effective. To talk to our case manager about CCSVI treatment with us in Mexico, where we have an interventional cardiologist who trained at Stanford University as well as neurologist working on every CCSVI procedure and where we ensure every CCSVI patient stays in hospital for up to 5 days after their treatment, please just contact us using the form on the right.